{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T17:03:16Z","timestamp":1770051796914,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Surg Oncol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s13193-025-02288-7","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T04:11:21Z","timestamp":1744344681000},"page":"41-48","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Effect of Melatonin on Endometrial Histology in Patients with Endometrial Proliferative Disorders: A Double-Blind Randomized Clinical Trial"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7140-5590","authenticated-orcid":false,"given":"Dina","family":"Salehi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parvin Mostafa","family":"Gharebaghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehri","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Vaezi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hosein","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javad","family":"Valipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,11]]},"reference":[{"issue":"5","key":"2288_CR1","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1530\/REP-06-0302","volume":"133","author":"GA Wood","year":"2007","unstructured":"Wood GA, Fata JE, Watson KLM et al (2007) Circulating hormones and estrous stage predict cellular and stromal remodeling in murine uterus. Reproduction 133(5):1035\u20131044","journal-title":"Reproduction"},{"issue":"2","key":"2288_CR2","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00441-015-2117-8","volume":"361","author":"S Nimbkar-Joshi","year":"2015","unstructured":"Nimbkar-Joshi S, Katkam RR, Kakar R et al (2015) Proliferation and decidualization of endometrial stromal cells during embryo-attachment stage in bonnet monkeys (Macaca radiata). Cell Tissue Res 361(2):605\u2013617","journal-title":"Cell Tissue Res"},{"key":"2288_CR3","doi-asserted-by":"crossref","unstructured":"Neykova K, Tosto V, Giardina I et al (2020). Endometrial receptivity and pregnancy outcome. J Matern-Fetal Neonatal Med 35(13):2591\u20132605","DOI":"10.1080\/14767058.2020.1787977"},{"issue":"2","key":"2288_CR4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10815-018-1343-x","volume":"36","author":"NK Kurian","year":"2019","unstructured":"Kurian NK, Modi D (2019) Extracellular vesicle-mediated embryo-endometrial cross-talk during implantation and in pregnancy. J Assist Reprod Genet 36(2):189\u2013198","journal-title":"J Assist Reprod Genet"},{"issue":"39","key":"2288_CR5","doi-asserted-by":"publisher","first-page":"14295","DOI":"10.1073\/pnas.1209249111","volume":"111","author":"Y Liu","year":"2014","unstructured":"Liu Y, Johnson BP, Shen AL et al (2014) Loss of BMAL1 in ovarian steroidogenic cells results in implantation failure in female mice. Proc Natl Acad Sci 111(39):14295\u201314300","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"2288_CR6","first-page":"7","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68(1):7\u201330","journal-title":"CA Cancer J Clin"},{"key":"2288_CR7","doi-asserted-by":"crossref","unstructured":"Chou AJ, Bing RS, Ding DC (2024) Endometrial atypical hyperplasia and risk of endometrial cancer. Diagnostics (Basel) 14(22):2471.","DOI":"10.3390\/diagnostics14222471"},{"issue":"9","key":"2288_CR8","first-page":"40","volume":"46","author":"S Ivanov","year":"2007","unstructured":"Ivanov S, Batashki I (2007) Screening methods for precancer and cancer of the endometrium. Akusherstvo i Ginekologiia 46(9):40\u201342","journal-title":"Akusherstvo i Ginekologiia"},{"issue":"6","key":"2288_CR9","first-page":"45","volume":"45","author":"S Ivanov","year":"2006","unstructured":"Ivanov S (2006) Early finding of endometrial precancer and cancer in women with combined risk factors. Akusherstvo i Ginekologiia 45(6):45\u201345","journal-title":"Akusherstvo i Ginekologiia"},{"issue":"12","key":"2288_CR10","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1016\/j.ejca.2008.05.001","volume":"44","author":"F Linkov","year":"2008","unstructured":"Linkov F, Edwards R, Balk J et al (2008) Endometrial hyperplasia, endometrial cancer, and prevention: gaps in existing research of modifiable risk factors. Eur J Cancer 44(12):1632\u20131644","journal-title":"Eur J Cancer"},{"issue":"6","key":"2288_CR11","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1093\/aje\/kwn168","volume":"168","author":"M Epplein","year":"2008","unstructured":"Epplein M, Reed SD, Voigt LF et al (2008) Risk of complex and atypical endometrial hyperplasia in relation to anthropometric measures and reproductive history. Am J Epidemiol 168(6):563\u2013570","journal-title":"Am J Epidemiol"},{"issue":"4","key":"2288_CR12","doi-asserted-by":"publisher","first-page":"608","DOI":"10.4103\/2141-9248.139340","volume":"4","author":"S Hebbar","year":"2014","unstructured":"Hebbar S, Chaya V, Rai L et al (2014) Factors influencing endometrial thickness in postmenopausal women. Ann Med Health Sci Res 4(4):608\u2013614","journal-title":"Ann Med Health Sci Res"},{"issue":"3","key":"2288_CR13","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.reprotox.2008.03.005","volume":"25","author":"H Tamura","year":"2008","unstructured":"Tamura H, Nakamura Y, Terron MP et al (2008) Melatonin and pregnancy in humans. Reprod Toxicol 25(3):291\u2013303","journal-title":"Reprod Toxicol"},{"issue":"1","key":"2288_CR14","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/j.1749-6632.2001.tb03626.x","volume":"939","author":"G Oxenkrug","year":"2001","unstructured":"Oxenkrug G, Requintina P, Bachurin S (2001) Antioxidant and antiaging activity of N-acetylserotonin and melatonin in the in vivo models. Ann New York Acad Sci 939(1):190\u2013199","journal-title":"Ann New York Acad Sci"},{"issue":"2","key":"2288_CR15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2174\/1568026023394335","volume":"2","author":"JM Guerrero","year":"2002","unstructured":"Guerrero JM, Reiter RJ (2002) Melatonin-immune system relationships. Curr Top Med Chem 2(2):167\u2013179","journal-title":"Curr Top Med Chem"},{"issue":"10","key":"2288_CR16","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1096\/fj.10-154450","volume":"24","author":"F Luchetti","year":"2010","unstructured":"Luchetti F, Canonico B, Betti M et al (2010) Melatonin signaling and cell protection function. FASEB J 24(10):3603\u20133624","journal-title":"FASEB J"},{"issue":"10","key":"2288_CR17","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1200\/JCO.2002.11.004","volume":"20","author":"Vijayalaxmi","year":"2002","unstructured":"Vijayalaxmi, Thomas CR Jr, Reiter RJ et al (2002) Melatonin: from basic research to cancer treatment clinics. J Clin Oncol 20(10):2575\u20132601","journal-title":"J Clin Oncol"},{"issue":"3","key":"2288_CR18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1177\/1534735408322846","volume":"7","author":"V Srinivasan","year":"2008","unstructured":"Srinivasan V, Spence DW, Pandi-Perumal SR et al (2008) Therapeutic actions of melatonin in cancer: possible mechanisms. Integr Cancer Ther 7(3):189\u2013203","journal-title":"Integr Cancer Ther"},{"issue":"6","key":"2288_CR19","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1177\/074873049701200606","volume":"12","author":"SM Reppert","year":"1997","unstructured":"Reppert SM (1997) Melatonin receptors: molecular biology of a new family of G protein-coupled receptors. J Biol Rhythms 12(6):528\u2013531","journal-title":"J Biol Rhythms"},{"issue":"20","key":"2288_CR20","doi-asserted-by":"publisher","first-page":"9789","DOI":"10.1158\/0008-5472.CAN-06-1776","volume":"66","author":"B Jung","year":"2006","unstructured":"Jung B, Ahmad N (2006) Melatonin in cancer management: progress and promise. Cancer Res 66(20):9789\u20139793","journal-title":"Cancer Res"},{"issue":"7","key":"2288_CR21","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1007\/s00018-003-2319-1","volume":"60","author":"RM Sainz","year":"2003","unstructured":"Sainz RM, Mayo JC, Rodriguez C et al (2003) Melatonin and cell death: differential actions on apoptosis in normal and cancer cells. Cell Mol Life Sci CMLS 60(7):1407\u20131426","journal-title":"Cell Mol Life Sci CMLS"},{"issue":"3","key":"2288_CR22","doi-asserted-by":"publisher","first-page":"R183","DOI":"10.1530\/ERC-15-0030","volume":"22","author":"SM Hill","year":"2015","unstructured":"Hill SM, Belancio VP, Dauchy RT et al (2015) Melatonin: an inhibitor of breast cancer. Endocrine-Relat Cancer 22(3):R183\u2013R204","journal-title":"Endocrine-Relat Cancer"},{"issue":"6","key":"2288_CR23","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1517\/13543784.2012.681045","volume":"21","author":"EJ Sanchez-Barcelo","year":"2012","unstructured":"Sanchez-Barcelo EJ, Mediavilla MD, Alonso-Gonzalez C et al (2012) Melatonin uses in oncology: breast cancer prevention and reduction of the side effects of chemotherapy and radiation. Expert Opin Investig Drugs 21(6):819\u2013831","journal-title":"Expert Opin Investig Drugs"},{"issue":"6","key":"2288_CR24","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.pain.2013.02.025","volume":"154","author":"A Schwertner","year":"2013","unstructured":"Schwertner A, Dos Santos CCC, Costa GD et al (2013) Efficacy of melatonin in the treatment of endometriosis: a phase II, randomized, double-blind, placebo-controlled trial. PAIN\u00ae 154(6):874\u2013881","journal-title":"PAIN\u00ae"},{"key":"2288_CR25","doi-asserted-by":"publisher","unstructured":"Esmaeili ED, Fakhari A, Naghili B, Khodamoradi F, Azizi H (2022) Case fatality and mortality rates, socio-demographic profile, and clinical features of COVID-19 in the elderly population: a populationbased registry study in Iran. J Med Virol 94(5):2126\u20132132. https:\/\/doi.org\/10.1002\/jmv.27594","DOI":"10.1002\/jmv.27594"},{"key":"2288_CR26","doi-asserted-by":"publisher","first-page":"e05142","DOI":"10.1016\/j.heliyon.2020.e05142","volume":"6","author":"MC Sivas","year":"2020","unstructured":"Sivas MC, Tapisiz OL, Ayik RT, Kahraman D, Altinbas SK, Tekin OM (2020) Effects of melatonin on uterine hypertrophy\/hyperplasia: A preliminary experimental rat study. Heliyon 6:e05142","journal-title":"Heliyon"},{"issue":"7","key":"2288_CR27","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/humrep\/dez082","volume":"34","author":"AA Mosher","year":"2019","unstructured":"Mosher AA, Tsoulis MW, Lim J et al (2019) Melatonin activity and receptor expression in endometrial tissue and endometriosis. Hum Reprod 34(7):1215\u20131224","journal-title":"Hum Reprod"},{"key":"2288_CR28","doi-asserted-by":"publisher","unstructured":"Lin PH, Tung YT, Chen HY et al (2020) Melatonin activates cell death programs for the suppression of uterine leiomyoma cell proliferation. J Pineal Res 68(1):e12620. https:\/\/doi.org\/10.1111\/jpi.12620","DOI":"10.1111\/jpi.12620"},{"issue":"23","key":"2288_CR29","doi-asserted-by":"publisher","first-page":"10067","DOI":"10.7314\/APJCP.2014.15.23.10067","volume":"15","author":"AD Tabrizi","year":"2014","unstructured":"Tabrizi AD, Melli MS, Foroughi M, Ghojazadeh M, Bidadi S (2014) Antiproliferative effect of metformin on the endometrium\u2013a clinical trial. Asian Pac J Cancer Prev. 15(23):10067\u201370","journal-title":"Asian Pac J Cancer Prev."},{"issue":"6","key":"2288_CR30","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s00404-015-3749-3","volume":"292","author":"M Emarh","year":"2015","unstructured":"Emarh M (2015) Cyclic versus continuous medroxyprogesterone acetate for treatment of endometrial hyperplasia without atypia: a 2-year observational study. Arch Gynecol Obstet. 292(6):1339\u201343","journal-title":"Arch Gynecol Obstet."},{"key":"2288_CR31","doi-asserted-by":"publisher","unstructured":"Elassall GM, Sayed EG, Abdallah NA, El-Zohiry MM, Radwan AA, AlMahdy ABM et al (2022) Levonorgestrel-releasing intrauterine system versus systemic progestins in management of endometrial hyperplasia: a systemic review and meta-analysis. J Gynecol Obstet Hum Reprod 51(8):102432.\u00a0https:\/\/doi.org\/10.1016\/j.jogoh.2022.102432","DOI":"10.1016\/j.jogoh.2022.102432"}],"container-title":["Indian Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13193-025-02288-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13193-025-02288-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13193-025-02288-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T06:20:47Z","timestamp":1770013247000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13193-025-02288-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["2288"],"URL":"https:\/\/doi.org\/10.1007\/s13193-025-02288-7","relation":{},"ISSN":["0975-7651","0976-6952"],"issn-type":[{"value":"0975-7651","type":"print"},{"value":"0976-6952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,11]]},"assertion":[{"value":"11 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical Considerations\n                      All ethical considerations for observational studies, including the ethical use of documents and scientific evidence in executing this thesis, were adhered to. No disclosures that could jeopardize the intellectual property rights of the participants were present in this study. All patients were fully informed about the study by reviewing and approving the informed consent form, and the patients incurred no additional costs. All aspects of the Helsinki Declaration regarding the findings' conduct, collection, interpretation, and publication were considered. Additionally, the proposal for this study was approved by the Regional Ethics Committee with the code IR.TBZMED.REC.1402.060 registered with the Clinical Trials Center of Iran under the code IRCT20120922010901N10.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interests"}},{"value":"The study protocol was registered and confirmed in the Iranian Registry of Clinical Trials under the number (IRCT20120922010901N10).\n                      Registration date:\n                      1402\/02\/18 , 2023-05-08\n                      URL to registration on the trial registry website:\n                      \n                      Date of enrollment of the first subject:\n                      1402\/02\/18, 2023-05-08","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Trial Registration"}}]}}